Literature DB >> 22504460

The role of T cell apoptosis in nervous system autoimmunity.

C Comi1, T Fleetwood, U Dianzani.   

Abstract

Fas is a transmembrane receptor involved in the death program of several cell lines, including T lymphocytes. Deleterious mutations hitting genes involved in the Fas pathway cause the autoimmune lymphoprolipherative syndrome (ALPS). Moreover, defective Fas function is involved in the development of common autoimmune diseases, including autoimmune syndromes hitting the nervous system, such as multiple sclerosis (MS) and chronic inflammatory demyelinating polyneuropathy (CIDP). In this review, we first explore some peculiar aspects of Fas mediated apoptosis in the central versus peripheral nervous system (CNS, PNS); thereafter, we analyze what is currently known on the role of T cell apoptosis in both MS and CIDP, which, in this regard, may be seen as two faces of the same coin. In fact, we show that, in both diseases, defective Fas mediated apoptosis plays a crucial role favoring disease development and its chronic evolution.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22504460     DOI: 10.1016/j.autrev.2011.08.011

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  19 in total

1.  Diet as a strategy for type 1 diabetes prevention.

Authors:  Flavia Prodam; Annalisa Chiocchetti; Umberto Dianzani
Journal:  Cell Mol Immunol       Date:  2017-07-10       Impact factor: 11.530

2.  Biological evaluation of subglutinol a as a novel immunosuppressive agent for inflammation intervention.

Authors:  Regina Lin; Hyoungsu Kim; Jiyong Hong; Qi-Jing Li
Journal:  ACS Med Chem Lett       Date:  2014-03-12       Impact factor: 4.345

3.  Defective expression of apoptosis-related molecules in multiple sclerosis patients is normalized early after autologous haematopoietic stem cell transplantation.

Authors:  G L V de Oliveira; A F Ferreira; E P L Gasparotto; S Kashima; D T Covas; C T Guerreiro; D G Brum; A A Barreira; J C Voltarelli; B P Simões; M C Oliveira; F A de Castro; K C R Malmegrim
Journal:  Clin Exp Immunol       Date:  2016-12-23       Impact factor: 4.330

4.  Variations of the perforin gene in patients with chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  S Buttini; G Cappellano; P Ripellino; C Briani; D Cocito; M Osio; R Cantello; U Dianzani; C Comi
Journal:  Genes Immun       Date:  2014-10-30       Impact factor: 2.676

5.  The prediction effects of thyroid function in the severity of Guillain-Barré syndrome.

Authors:  Lingxin Kong; Xiujuan Wu; Yanwei Cheng; Shan Liu; Kangding Liu; Chunrong Li
Journal:  Neurol Sci       Date:  2022-04-26       Impact factor: 3.830

Review 6.  Serpins, immunity and autoimmunity: old molecules, new functions.

Authors:  Mariele Gatto; Luca Iaccarino; Anna Ghirardello; Nicola Bassi; Patrizia Pontisso; Leonardo Punzi; Yehuda Shoenfeld; Andrea Doria
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

7.  Immunity and inflammation in neurodegenerative diseases.

Authors:  Giuseppe Cappellano; Miryam Carecchio; Thomas Fleetwood; Luca Magistrelli; Roberto Cantello; Umberto Dianzani; Cristoforo Comi
Journal:  Am J Neurodegener Dis       Date:  2013-06-21

8.  Treatment for experimental autoimmune neuritis with clodronate (Bonefos).

Authors:  Aviva Katzav; Hofit Bina; Ramona Aronovich; Joab Chapman
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

Review 9.  Autoimmunity in 2012.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

10.  The impact of osteopontin gene variations on multiple sclerosis development and progression.

Authors:  Cristoforo Comi; Giuseppe Cappellano; Annalisa Chiocchetti; Elisabetta Orilieri; Sara Buttini; Laura Ghezzi; Daniela Galimberti; Franca Guerini; Nadia Barizzone; Franco Perla; Maurizio Leone; Sandra D'Alfonso; Domenico Caputo; Elio Scarpini; Roberto Cantello; Umberto Dianzani
Journal:  Clin Dev Immunol       Date:  2012-09-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.